FDA Forces the Only Drug for Preterm Births to Leave Market

대한민국 뉴스 뉴스

FDA Forces the Only Drug for Preterm Births to Leave Market
대한민국 최근 뉴스,대한민국 헤드 라인

The only drug approved by the FDA to prevent preterm births will longer be available. The agency said it is withdrawing its approval for the drug Makena due to its ineffectiveness.

  • 📰 WSJ
  • ⏱ Reading Time:
  • 23 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 13%
  • Publisher: 63%

The FDA typically nudges manufacturers to withdraw drugs voluntarily; it is rare for the agency to force a drug withdrawal.Updated April 6, 2023 10:46 am ET

The only drug on the market to help prevent preterm births must stop being sold immediately, a move that comes after scientists at the Food and Drug AdministrationThe FDA said Thursday it is withdrawing its approval for the drug Makena and its generics because the drugs no longer are shown to be effective and the benefits don’t outweigh the risks. Makena, as well as its generics, can no longer be lawfully distributed in interstate commerce.

이 소식을 빠르게 읽을 수 있도록 요약했습니다. 뉴스에 관심이 있으시면 여기에서 전문을 읽으실 수 있습니다. 더 많은 것을 읽으십시오:

WSJ /  🏆 98. in KR
 

Wat

If it doesn't work, it shouldn't be used.

대한민국 최근 뉴스, 대한민국 헤드 라인

Similar News:다른 뉴스 소스에서 수집한 이와 유사한 뉴스 기사를 읽을 수도 있습니다.

FDA forces unproven premature birth drug Makena off marketFDA forces unproven premature birth drug Makena off marketThe Food and Drug Administration is ordering an unproven drug intended to prevent premature births off the market
더 많은 것을 읽으십시오 »



Render Time: 2025-01-13 23:29:04